OSPRI Emerges from Merger to Revolutionize Infectious Disease Testing with Integrated PCR Platform

Merger Launches OSPRI, a Next‑Gen North Texas PCR Testing Company Backed by Up to $30M

A $30M merger of three companies has launched McKinney-based OSPRI, a PCR testing platform focused on infectious disease detection.

OSPRI Emerges from Merger to Revolutionize Infectious Disease Testing with Integrated PCR Platform

The biotechnology landscape has been reshaped by the merger of Community Direct DX, Scienetix, and Advanta Genetics R&D into OSPRI, forming one of the world’s first fully vertically-integrated molecular testing platforms. This consolidation addresses critical barriers in infectious disease detection by delivering an end-to-end solution that encompasses manufacturing, lab buildout, revenue cycle management, and regulatory support, enabling health…